Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

GENICA Network, kConFaB, AOCS Study Group, SWE-BRCA, HEBON, EMBRACE

Research output: Contribution to journalArticle

8 Citations (Scopus)
5 Downloads (Pure)

Abstract

Recently, a locus on chromosome 6q22.33 (rs2180341) was reported to be associated with increased breast cancer risk in the Ashkenazi Jewish (AJ) population, and this association was also observed in populations of non-AJ European ancestry. In the present study, we performed a large replication analysis of rs2180341 using data from 31,428 invasive breast cancer cases and 34,700 controls collected from 25 studies in the Breast Cancer Association Consortium (BCAC). In addition, we evaluated whether rs2180341 modifies breast cancer risk in 3,361 BRCA1 and 2,020 BRCA2 carriers from 11 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Based on the BCAC data from women of European ancestry, we found evidence for a weak association with breast cancer risk for rs2180341 (per-allele odds ratio (OR)¿=¿1.03, 95% CI 1.00-1.06, p¿=¿0.023). There was evidence for heterogeneity in the ORs among studies (I(2)¿=¿49.3%; p¿=¿
Original languageEnglish
Article numbere35706
Number of pages10
JournalPloS ONE
Volume7
Issue number6
DOIs
Publication statusPublished - 29 Jun 2012

Fingerprint Dive into the research topics of 'Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2'. Together they form a unique fingerprint.

  • Cite this